A 24-weeks pilot open-label prospective study of Dienogest in women with symptomatic rectovaginal endometriosis who had pain persistence.
Phase of Trial: Phase II
Latest Information Update: 01 Sep 2015
At a glance
- Drugs Dienogest (Primary)
- Indications Endometriosis; Pain
- Focus Therapeutic Use
- 01 Sep 2015 New trial record